Habs, M.; Binder, K.; Krauss, S.; Müller, K.; Ernst, B.; Valentini, L.; Koller, M.
A Balanced Risk–Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Tea and Herbal Infusions. Nutrients 2017, 9, 717.
https://doi.org/10.3390/nu9070717
AMA Style
Habs M, Binder K, Krauss S, Müller K, Ernst B, Valentini L, Koller M.
A Balanced Risk–Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Tea and Herbal Infusions. Nutrients. 2017; 9(7):717.
https://doi.org/10.3390/nu9070717
Chicago/Turabian Style
Habs, Michael, Karin Binder, Stefan Krauss, Karolina Müller, Brigitte Ernst, Luzia Valentini, and Michael Koller.
2017. "A Balanced Risk–Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Tea and Herbal Infusions" Nutrients 9, no. 7: 717.
https://doi.org/10.3390/nu9070717
APA Style
Habs, M., Binder, K., Krauss, S., Müller, K., Ernst, B., Valentini, L., & Koller, M.
(2017). A Balanced Risk–Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Tea and Herbal Infusions. Nutrients, 9(7), 717.
https://doi.org/10.3390/nu9070717